Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Blog articles 26.11.20
Bringing stakeholders together to improve patient access to oncology therapies in Europe (Guest blog)...
Every Day Counts: Accelerate Access, Beat Cancer
Read Article -
Blog articles 26.11.20
Podcast: Can we develop better medicines for children faster?
Welcome to 19 conversations
Read Article -
Blog articles 26.11.20
Can we move towards earlier diagnosis for Alzheimer’s? (Guest blog)
If a new medicine can successfully slow the damage done by this progressive disease, early detection and timely diagnosis will be essential to deliver...
Read Article -
External Events 04.02.21
9th ACCELERATE Paediatric Oncology Conference
REGISTRATION IS NOW OPEN with specially reduced rates available before the early rate deadline of 4 January 2021.
View Event -
External Events 25.02.21
2nd ICPerMed conference on Personalised Medicine - From Vision to Practice
New dates announced
View Event -
External Events 04.03.21
Value Based Healthcare Conference – Tallinn 2021
The conference aims at raising awareness and knowledge among the healthcare community on the value of patient-centered healthcare.
View Event
Featured Articles
